Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Game-Changing Small-Cap Healthcare Stocks


3 Game-Changing Small-Cap Healthcare Stocks

The ability to shake up patient treatment could mean big bucks for Tetraphase Pharmaceuticals (NASDAQ: TTPH), NovoCure (NASDAQ: NVCR), and Exact Sciences (NASDAQ: EXAS). Should you be buying shares in these companies? Read on to learn if they're right for your portfolio.

What happens when a highly anticipated phase 3 study fails to pan out? Shares get crushed. And that's precisely what happened when Tetraphase Pharmaceuticals reported in 2015 that its oral antibiotic, eravacycline, missed the mark as a treatment for urinary tract infection.

IMAGE SOURCE: GETTY IMAGES.

Continue reading


Source: Fool.com

Tetraphase Pharmaceuticals Stock

€0.22
-10.670%
Tetraphase Pharmaceuticals took a tumble today and lost -€0.026 (-10.670%).

Like: 0
Share

Comments